The need for human genetic material, protein and metabolites from cases and controls for gene-based, protein-based and other discovery research is firmly established. The complexity, cost, and time entailed in procuring appropriately consented samples suggests that pharmaceutical and biotech companies need to contract with specialists in this area. Genomics and proteomics research requires appropriately consented biological materials from cases and matched controls from an increasingly large number of subjects. In order to maintain competitive advantage, while concentrating on the complex gene discovery process, access to high quality, accurate phenotypic data is essential.

The PrecisionMed system enables our clients to work with DNA and other samples from accurately characterized clinical cases. The most appropriate system for sample procurement is the use of a network of specialists and family practitioners, linking them to a method for clinical data collection. PrecisionMed has the relationships for a successful network system and we use this and other systems for our current projects.